期刊文献+

BTG1在胃癌中的表达及其临床意义 被引量:2

Expression of BTG1 in gastric cancer and its clinical significance
下载PDF
导出
摘要 目的分析B细胞异位基因1(BTG1)在胃癌中的表达及其潜在临床意义。方法收集胃癌组织和相对应癌旁组织标本46例及健康胃黏膜组织标本31例,利用荧光定量PCR技术和免疫组织化学技术分别检测各标本中BTG1的mRNA和蛋白表达水平,分析BTG1在不同组织中的表达差异及与胃癌病理特征及预后的关系。结果胃癌组织中的BTG1表达水平显著低于正常癌旁组织及健康正常胃黏膜组织,差异有统计学意义(P<0.01)。BTG1表达与性别、年龄、肿瘤大小及组织学分型等临床病理因素无关,而与胃癌TNM分期有关,具体表现在(Ⅲ+Ⅳ)期胃癌标本BTG1表达水平显著低于(Ⅰ+Ⅱ)期,差异有统计学意义(P<0.01)。进一步分析发现,BTG1低表达与上皮间质转化过程显著相关;且BTG1表达水平越低,预后5年生存率越差,差异有统计学意义(P<0.01)。结论 BTG1在胃癌中低表达,与转归及预后高度相关,可作为胃癌的生物学指标之一。 Objective To investigate the expressions and potential clinical significances of BTG1 on gastric cancer.Methods Forty-six tissue samples of gastric cancer and the corresponding adjacent normal tissue samples and thirty-one gastric tissues of healthy adults were collected.The expressions of BTG1 in different tissue samples were detected by qRT-PCR.The correlations between the BTG1 expressions and clinical features as well as prognosis and development of gastric cancer were analyzed.Results The levels of BTG1 expression in gastric cancer tissue were significant lower than that in the adjacent normal tissue samples and healthy samples(P0.01).BTG1 was associated with TNM stages,but not with factors like age,sex,tumor size,tissue classification of gastric cancer;the levels of BTG1 in(Ⅲ + Ⅳ) stages were higher than that in(Ⅰ + Ⅱ) stages(P0.01).The expressions of BTG1 were highly correlated with epithelium mesenchymal transition of gastric cancer;and were negatively correlated with the 5-year survival rate of human with gastric cancer(P0.01).Conclusion The low expression of BTG1 in gastric cancer is highly correlated with prognosis and prognosis,which can be used as one of the biological indicators of gastric cancer.
作者 曾宪清 吴勤祥 张晓勇 李好朝 Zeng Xianqing;Wu Qinxiang;Zhang Xiaoyong(Second Dept of Surgery,The Affiliated Hospital of Nanyang Medical College,Nanyang 47305)
出处 《安徽医科大学学报》 CAS 北大核心 2018年第7期1106-1109,共4页 Acta Universitatis Medicinalis Anhui
基金 河南省高等学校重点科研项目(编号:16A310017)
关键词 胃癌 BTG1 转归 生存率 gastric cancer BTG1 outcome survival rate
  • 相关文献

参考文献1

二级参考文献10

  • 1Satohiro Matsumoto,Kazumi Yamasaki,Kenichiro Tsuji,Satoshi Shirahama.Results of mass endoscopic examination for gastric cancer in Kamigoto Hospital,Nagasaki Prefecture[J].World Journal of Gastroenterology,2007,13(32):4316-4320. 被引量:13
  • 2Wai K Leung,Ming-shiang Wu,Yasuo Kakugawa,Jae J Kim,Khay-guan Yeoh,Khean Lee Goh,Kai-chun Wu,Deng-chyang Wu,Jose Sollano,Udom Kachintorn,Takuji Gotoda,Jaw-town Lin,Wei-cheng You,Enders KW Ng,Joseph JY Sung.Screening for gastric cancer in Asia: current evidence and practice[J].Lancet Oncology.2008(3)
  • 3Satohiro Matsumoto,Yukio Yoshida.Efficacy of endoscopic screening in an isolated island: A case–control study[J].Indian Journal of Gastroenterology.2014(1)
  • 4Chisato Hamashima,Mikizo Okamoto,Michiko Shabana,Yoneatsu Osaki,Takuji Kishimoto.Sensitivity of endoscopic screening for gastric cancer by the incidence method[J].Int J Cancer.2013(3)
  • 5Rafael Lomba-Viana,Mário Dinis-Ribeiro,Fernando Fonseca,Anabela Silva Vieira,Maria José Bento Bento,Helena Lomba-Viana.Serum pepsinogen test for early detection of gastric cancer in a European Country[J].European Journal of Gastroenterology & Hepatology.2012(1)
  • 6Mariam AbdullahiAdamu,Melanie NicoleWeck,DietrichRothenbacher,HermannBrenner.Incidence and risk factors for the development of chronic atrophic gastritis: Five year follow‐up of a population‐based cohort study[J].Int J Cancer.2011(7)
  • 7Shigeto Mizuno,Ikuya Miki,Tsukasa Ishida,Masaru Yoshida,Mitsuko Onoyama,Takeshi Azuma,Yasuki Habu,Hideto Inokuchi,Kotaro Ozasa,Kazumasa Miki,Yoshiyuki Watanabe.Prescreening of a High-Risk Group for Gastric Cancer by Serologically Determined Helicobacter pylori Infection and Atrophic Gastritis[J].Digestive Diseases and Sciences.2010(11)
  • 8Osamu Hosokawa,Tamon Miyanaga,Yasuharu Kaizaki,Masakazu Hattori,Kenji Dohden,Kouji Ohta,Yoshitaka Itou,Hiroyuki Aoyagi.Decreased death from gastric cancer by endoscopic screening: Association with a population-based cancer registry[J].Scandinavian Journal of Gastroenterology.2008(9)
  • 9Masaharu Yoshihara,Toru Hiyama,Shigeto Yoshida,Masanori Ito,Shinji Tanaka,Yoshiyuki Watanabe,Ken Haruma.Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: A case-control study[J].Scandinavian Journal of Gastroenterology.2007(6)
  • 10MarcoZappa,GuidoCastiglione,EugenioPaci,GraziaGrazzini,TizianaRubeca,PatriciaTurco,EmanueleCrocetti,StefanoCiatto.Measuring interval cancers in population‐based screening using different assays of fecal occult blood testing: The district of Florence experience[J].Int J Cancer.2001(1)

共引文献46

同被引文献9

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部